Condition: End Stage Renal Disease · Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Investigators know that many patients who are on dialysis suffer from burden of unwanted symptoms, which can affect quality of life. The understanding and treatment of symptom burden by healthcare providers is limited and should be recognized as a high priority in the care of the dialysis population. In this study, the investigators will be assessing symptom burden using the London Evaluation of Illness "LEVIL," an application based platform where patients self-report their symptoms with one to three hemodialysis treatments per week for 28 weeks. The investigators would like to compare the currently available dialyzer with a new dialyzer that is capable of removing solutes of higher molecular weight that may or may not cause patients to experience symptoms related to increased amounts of toxins in their blood.
This description comes directly from the study's public registry record.
Christopher McIntyre, MBBS DM · 5196858500 · Christopher.McIntyre@lhsc.on.ca
Jarrin Penny, PHD RN CNeph · 519-685-8500 · jarrin.penny@lhsc.on.ca
Always discuss trial participation with your own doctor first.
| Seven Oaks Hospital Chronic Disease Innovation Centre Inc. (CDIC) | Winnipeg, Manitoba, Canada | Recruiting |
| QEII Health Sciences Centre, Nova Scotia Health | Halifax, Nova Scotia, Canada | Recruiting |
| Victoria Hospital, London Health Sciences Centre | London, Ontario, Canada | Recruiting |
| Westmount Kidney Care Centre | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06032208